ホーム>>Signaling Pathways>> Others>> Enzyme Substrates / Activators>>Akt Substrate (trifluoroacetate salt)

Akt Substrate (trifluoroacetate salt) (Synonyms: RPRAATF)

カタログ番号GC52443

アクトペプチド基質

Products are for research use only. Not for human use. We do not sell to patients.

Akt Substrate (trifluoroacetate salt) 化学構造

サイズ 価格 在庫数 個数
5 mg
$70.00
在庫あり
10 mg
$126.00
在庫あり
25 mg
$277.00
在庫あり
50 mg
$486.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Background

Akt基質は、増殖、生存性、血管新生、およびグルコース代謝などの様々な細胞プロセスに関与するセリン/トレオニンキナーゼであるAktのペプチド基質です。1 Akt活性の定量化のターゲット基質として使用されています。

1. Bozinovski、S.、Cristiano、B.E.、Marmy-Conus、N.、他。RPRAATF合成ペプチドによる細胞リザート中のAkt活性の特異的アッセイが可能となります。Anal.Biochem.305(1)32-39(2002)

Chemical Properties

Cas No. SDF Download SDF
同義語 RPRAATF
Canonical SMILES OC([C@H](CC1=CC=CC=C1)NC([C@H]([C@H](O)C)NC([C@H](C)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H]2N(C([C@H](CCCNC(N)=N)N)=O)CCC2)=O)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
Formula C36H59N13O9 ? XCF3COOH M.Wt 817.9
溶解度 DMF: insol,DMSO: 10 mg/ml,Ethanol: insol,PBS (pH 7.2): 5 mg/ml Storage -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 1.2226 mL 6.1132 mL 12.2264 mL
5 mM 0.2445 mL 1.2226 mL 2.4453 mL
10 mM 0.1223 mL 0.6113 mL 1.2226 mL
  • モルアリティ計算機

  • 希釈計算機

質量
=
濃度
x
容積
x
MW*
 
 
 
**ストックソリューションを準備する際には、常にバイアルラベルおよび MSDS/CoA(オンラインで利用可能)で掲載された製品のロット固有分子量を使用してください。

計算

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

レビュー

Review for Akt Substrate (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Akt Substrate (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.